Matthew A. Clarke
@maclarke.bsky.social
Computational biologist and mechanistic interpretability researcher. For more find me at: https://mclarke1991.github.io & https://www.linkedin.com/in/matthew-alan-clarke/
Pinned
Matthew A. Clarke
@maclarke.bsky.social
· Jan 12
To get things started on Bluesky, here is a thread of the research I have been part of so far! For details on all of these and more, please see my website: mclarke1991.github.io
Excited to share our new preprint showcasing a method to infer transparent, mechanistic network models of biological pathways using graph neural networks! www.biorxiv.org/content/10.1...
May 26, 2025 at 9:50 PM
Excited to share our new preprint showcasing a method to infer transparent, mechanistic network models of biological pathways using graph neural networks! www.biorxiv.org/content/10.1...
Reposted by Matthew A. Clarke
We then used our published method from @charliegbarker.bsky.social (Barker et al, Genome Research, 2022) to create a reference MASLD network by associating gene co-expression modules with histology scores, identifying key transcription factors regulating them and applying network reconstruction.
January 19, 2025 at 11:18 AM
We then used our published method from @charliegbarker.bsky.social (Barker et al, Genome Research, 2022) to create a reference MASLD network by associating gene co-expression modules with histology scores, identifying key transcription factors regulating them and applying network reconstruction.
Excited to be working on gradient routing as part of Supervised Program for Alignment Research with Alex Cloud, Ariana Azarbal, Cailley Factor & Jorio Cocola. We hope to build safer AI by controlling where and how neural networks learn. See here for more: www.lesswrong.com/posts/tAnHM3...
March 28, 2025 at 5:46 PM
Excited to be working on gradient routing as part of Supervised Program for Alignment Research with Alex Cloud, Ariana Azarbal, Cailley Factor & Jorio Cocola. We hope to build safer AI by controlling where and how neural networks learn. See here for more: www.lesswrong.com/posts/tAnHM3...
Reposted by Matthew A. Clarke
🚨 New preprint!🚨 Tackling non-small cell lung cancer (NSCLC) adenocarcinoma with in silico models:
🌟 Models tumor pathways (EGFR, AKT, JAK/STAT, WNT)
🌟 personalized drug & radiotherapy combos
🌟 Identifies a signature for patient stratification
🌟 Models tumor pathways (EGFR, AKT, JAK/STAT, WNT)
🌟 personalized drug & radiotherapy combos
🌟 Identifies a signature for patient stratification
January 13, 2025 at 11:04 AM
🚨 New preprint!🚨 Tackling non-small cell lung cancer (NSCLC) adenocarcinoma with in silico models:
🌟 Models tumor pathways (EGFR, AKT, JAK/STAT, WNT)
🌟 personalized drug & radiotherapy combos
🌟 Identifies a signature for patient stratification
🌟 Models tumor pathways (EGFR, AKT, JAK/STAT, WNT)
🌟 personalized drug & radiotherapy combos
🌟 Identifies a signature for patient stratification
Excited to share our new preprint exploring the potential to personalise treatment for non-small cell lung cancer (NSCLC) using in silico modeling: www.biorxiv.org/content/10.1...
January 12, 2025 at 5:29 PM
Excited to share our new preprint exploring the potential to personalise treatment for non-small cell lung cancer (NSCLC) using in silico modeling: www.biorxiv.org/content/10.1...
To get things started on Bluesky, here is a thread of the research I have been part of so far! For details on all of these and more, please see my website: mclarke1991.github.io
January 12, 2025 at 3:19 PM
To get things started on Bluesky, here is a thread of the research I have been part of so far! For details on all of these and more, please see my website: mclarke1991.github.io
Reposted by Matthew A. Clarke
I got a bsky so that i could repost this!! Full publication to follow shortly but, would appreciate your feedback on the methods and results! 🔭🧪
We are proud to present "ARID1A-induced transcriptional reprogramming rewires signalling responses to drug treatment in melanoma" led by Charlie Barker and Sumana Sharma in collaboration with EPIC-XS Utrecht, ProtAvio, @sangerinstitute.bsky.social and UofAthens www.biorxiv.org/content/10.1...
ARID1A-induced transcriptional reprogramming rewires signalling responses to drug treatment in melanoma
Resistance to BRAF and MAPK inhibitors is a significant challenge in melanoma treatment, driven by adaptive and acquired mechanisms that allow tumour cells to evade therapy. Here, we examined early si...
www.biorxiv.org
December 10, 2024 at 2:04 PM
I got a bsky so that i could repost this!! Full publication to follow shortly but, would appreciate your feedback on the methods and results! 🔭🧪